Zdravko is a Manager for Business Development and Operations at Pangea Bio. He is contributing to crafting our go-to-market strategy and active on our clinical development programmes.
Zdravko was previously a senior analyst at Windrose Consulting Group, where he provided strategic pricing and market access recommendations across various indications and global markets. He also spent time at Compass Pathways, working on market access payer and physicians reach-out initiatives.
Zdravko studied Natural Sciences at Cambridge University and also holds an MSc in Health Policy from London School of Economics.